|
Home | Medical-Newswire.Com:
|
(Medical-NewsWire.com, June 11, 2019 ) BRIC IVD Market by Product & Service (Instruments, Reagents, Software), Technology (Immunoassay, Hematology, Microbiology), Application (Diabetes, Cardiology, Infectious Diseases), Country (Brazil, Russia, India, China)
The key factors driving the growth of the market are growing patient awareness of personalized medicine, increasing prevalence of lifestyle and chronic diseases, growth in the number of private diagnostic centers, and improving healthcare system in emerging countries.
Download FREE Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=198
However, BRIC IVD Market growth is restrained by the lack of reimbursement and the slow growth of the economy in some emerging countries.
This research study involved the extensive use of both primary and secondary data sources as well as various factors affecting the industry, including the regulatory landscape; competitive scenario; historic data; current trends in the market; technological innovations and upcoming technologies; and market drivers, restraints, opportunities, and challenges.
The key players in this BRIC IVD Market are Roche Diagnostics (Switzerland), Abbott Laboratories Inc. (U.S.), Siemens Healthineers (Germany), Danaher Corporation (U.S.), Thermo Fisher Scientific Inc. (U.S.), Sysmex Corporation (Japan), Bio-Rad Laboratories, Inc. (U.S.), bioMérieux (France), and Becton, Dickinson and Company (U.S.), Johnson & Johnson (U.S.), QIAGEN N.V. (Germany), Ortho-Clinical Diagnostics, Inc. (U.S.), and Diasorin S.P.A. (Italy).
Request for Sample @ https://www.marketsandmarkets.com/requestsampleNew.asp?id=198
Target Audience
-IVD product manufacturers
-Group purchase organizations (GPOs)
-Original equipment manufacturers (OEM)
-Pathologists and pathology laboratories
-Distributors of IVD products
-Hospitals and clinics
-Healthcare institutions
MarketsandMarkets™
Mr. Shelly Singh
1-888-600-6441
raviraj.tak@marketsandmarkets.com
Source: EmailWire.Com 
Source: EmailWire.com
|
|
|
|
